INTRODUCTION
It has been speculated that more than 400 bacterial species reside in the oral cavity, and some cause inflammation such as that seen in periodontitis. Oral mucosal cells such as epithelial cells are thought to act as a physical barrier against the invasion of pathogenic organisms. In addition, oral (gingival) epithelial cells in inflamed regions appear to express several pro-inflammatory cytokines (such as IL-1 , IL-6, IL-8 and TNF-), 1 and adhesion molecules. 2, 3 In periodontitis, hemopoietic immune cells such as T cells, B cells, monocytes and neutrophils are recruited and accumulate at inflamed areas. This evidence implies that the oral mucosal cells actively participate in infiltration of the immune cells by producing pro-inflammatory cytokines and by interacting with the immune cells by adhesion molecules. They consequently initiate and develop chronic oral inflammation such as periodontitis. However, only a few studies have demonstrated cytokine production by human gingival epithelial cells and related cell lines derived from the oral cavity in response to oral bacteria. 2, 3 The present study focused on the regulation of innate immune responses of human oral epithelial cells to bacterial cell-surface components.
Saliva, a complex mix of fluids from major (parotid, submandibular, and sublingual) and minor salivary glands, is a most valuable oral fluid that is critical to the preservation and maintenance of oral health. 4, 5 Saliva contains a number of proteins and glycoproteins that protect oral tissues, but little is known about the role of human saliva in innate immunity. The present study shows that major salivary glands constitutively express and secrete bio-active CD14 into saliva in a soluble form.
MATERIALS AND METHODS

Cells, cell lines and saliva
The human oral epithelial cell lines HSC-2, and KB, established from squamous cell carcinoma, were obtained from the Cancer Cell Repository, Institute of
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It is speculated that more than 400 bacterial species reside in the oral cavity. Some cause inflammation (e.g. periodontitis), understanding of which requires examination of innate immunity in the oral cavity. Oral mucosal cells such as epithelial cells are thought to act as a physical barrier against the invasion of pathogenic organisms, but they have an ability to produce inflammatory cytokines and express adhesion molecules. Oral epithelial cells are refractory to many bacterial components although they express Toll-like receptors/MyD88, and acquire responsiveness after priming with IFN-. When the cells are stimulated with lipopolysaccharide (LPS) and neutrophil protease (PR3) after IFN-priming, the cells produce bio-active IL-18, which is critical to Th1 and Th2 responses. PR3 itself is able to activate the cells through G protein-coupled protease-activated receptor-2 on the cell surface. These results suggest that innate immune responses of oral epithelial cells to bacterial components are regulated in the inflammatory process. In addition, saliva contains abundant bio-active CD14 from salivary glands in a soluble form, although LPS-binding protein was below detectable levels, suggesting that saliva CD14 is important for the maintenance of oral health.
Development, Aging and Cancer, Tohoku University (HSC-2; Sendai, Japan) and from the Health Science Research Resources Bank (KB; Tokyo, Japan), respectively. A human colon adenocarcinoma cell line SW620 was obtained from the American Type Culture Collection (Rockville, MD, USA). 6 HSC-2 and SW620 were grown in RPMI 1640 medium with 10% heat-inactivated fetal calf serum (FCS; Life Technologies, Grand Island, NY, USA) and KB was grown in -minimal essential medium with 10% FCS with a medium change every 3 days. 6 Human gingival epithelial cells were prepared from explants of normal human gingival tissues with informed consent as described previously. 7 Whole saliva was collected by allowing adult healthy donors, aged 22-24 years, to expectorate into a sterile plastic tube after the collection of parotid saliva. Parotid saliva was collected with the aid of Schaefer cups placed over Stenson's duct. Stimulated saliva was collected by chewing a wax piece. The saliva samples were immediately clarified by centrifugation at 14,000 g for 5 min at 4°C. Clarified saliva samples were collected, aliquoted and frozen at -70°C until use.
The experimental procedures were approved by the Ethical Review Board of Tohoku University School of Dentistry (Sendai, Japan).
Measurement of cytokines, CD14 and LBP
Confluent oral epithelial cells were collected by nonenzymatic cell dissociation solution and washed 3 times in phosphate-buffered saline. The cells (10 4 
cells/200 ml)
were seeded in culture medium in 96-well plates (Falcon; Becton Dickinson Labware, Lincoln Park, NJ, USA). After incubation for 1 day at 37°C in a 5% CO 2 incubator, the cells were stimulated with test materials in 200 ml of the medium without serum for 24 h. Cultivation was carried out in triplicate, and levels of cytokines in the supernatants were measured using OptEIA enzyme-linked immunosorbent assay (ELISA) kits (PharMingen, San Diego, CA, USA). Levels of CD14 and lipopolysaccharide (LPS)-binding protein (LBP) in the supernatants and human saliva were measured using a human sCD14 ELISA kit (BioSource Europe, Fleurus, Belgium) and a human LBP ELISA kit (HyCult Biotechnology, Uden, The Netherlands).
Miscellaneous
Bacterial components, other reagents and methods such as reverse transcriptase-polymerase chain reaction (RT-PCR), flow cytometry, Western blotting, analysis of peptide cleavage and calcium mobilization were performed as described previously. [6] [7] [8] [9] [10] [11] 
RESULTS AND DISCUSSION
Regulation of innate immune response of oral epithelial cells to bacterial cell-surface components
First, the study examined whether oral epithelial cells produced IL-8 in response to Salmonella LPS, Staphylococcus aureus and Bacillus subtilis lipoteichoic acid (LTA), S. aureus peptidoglycan (PGN), a water soluble PGN, Staphylococcus epidermidis peptidoglycan SALEendopeptidase digest (SEPS), and muramyldipeptide. Primary gingival epithelial cells, oral epithelial HSC-2 and KB cells did not secrete IL-8 in response to the bacterial components even in the presence of serum (Fig. 1A) . 6 The mechanism underlying the unresponsiveness of the epithelial cells is not clear at present.
Under the same conditions, treatment with IFN-(1000 U/ml) for 3 days made the oral epithelial cells responsive to stimulation with the bacterial components, resulting in the production of IL-8 and granulocyte macrophage-colony stimulating factor (GM-CSF; Fig.  1C ). 9 Marked IL-8 secretion in response to LPS was observed when the cells were treated with IFN-(1000 and 10,000 U/ml for 3 days). Treatment with IFN-for 1 and 2 days was not sufficient, whereas after IFN-priming for 3 days, LPS significantly activated the cells to secrete IL-8. HSC-2 cells were treated with IFN-(1000 U/ml) for 3 days, then RT-PCR was performed to detect levels of CD14, Toll-like receptor (TLR) 2, TLR4, MD-2 or MyD88 mRNA expression. The expression of these molecules, except for CD14, was significantly up-regulated by IFN-, 9 suggesting that the up-regulation of the TLR system may account for the production of the cytokines in response to bacterial components. In addition, treatment with IFN-might have directly modulated intracellular function of oral epithelial cells.
IL-18 is important for Th1 response by inducing IFNtogether with IL-12. 12 In the absence of IL-12, IL-18 also has the capacity to stimulate Th2 response such as allergy. 13 Oral epithelial cells constitutively express IL-18 mRNA and the 24-kDa precursor form of IL-18 in the cells. 10 Secretion of a bio-active 18-kDa form of IL-18 was induced from the cells on co-stimulation with neutrophil proteinase 3 (PR3) and LPS for 24 h after IFNpriming for 3 days (Fig. 1D ). PR3, a 29-kDa serine proteinase secreted from activated neutrophils, is suggested to contribute actively to inflammatory processes. Therefore, we focused on the mechanism by which PR3 activates oral epithelial cells. PR3 cleaved the peptide corresponding to the N-terminus of protease-activated receptor-2 (PAR-2) with exposure of its tethered ligand. Treatment with trypsin, an agonist for PAR-2, and a synthetic PAR-2 agonist peptide induced intracellular calcium mobilization, and rendered the cells refractory to subsequent stimulation with PAR-2. Consequently, PR3 alone activated the cells to produce IL-8 and monocyte chemo-attractant protein-1 (MCP-1) and to express intercellular adhesion molecule-1 (ICAM-1) in a doseand time-dependent manner (Fig. 1B) . 11 These findings suggest that neutrophil PR3 can activate oral epithelial cells through G protein-coupled PAR-2 (Fig. 1B,D) . These results suggest that innate immune responses of oral epithelial cells are regulated in the inflammatory process.
Saliva CD14
Immunohistochemistry showed that CD14 protein was present in the acinar and intercalated duct cells of tissues from human parotid gland, a serous gland. In the section of human submandibular gland, a mixed gland of serous and mucous cells, CD14 was expressed only in serous cells but not in mucous cells. In whole saliva, the 55-kDa form of CD14 with the same M r as in human monocytes was detected, and 55-kDa CD14 was more abundant in parotid saliva than whole saliva by immunoblot analysis. The levels of CD14 in unstimulated whole and parotid saliva as assessed by ELISA were 0.19 ± 0.01 mg/ml (mean ± SD; n = 8) and 1.44 ± 0.97 mg/ml (mean ± SD;
Innate immune responses in oral mucosa 467 Fig. 2 . Biological functions of saliva CD14. (A) SW620 cells were incubated with given doses of parotid saliva in the presence or absence of LPS (100 ng/ml) for 24 h. (B) SW620 cells were stimulated with LPS (100 ng/ml) in the presence of either parotid saliva (2%) or rCD14 (50 ng/ml) for 24 h. Cells were pretreated with anti-CD14 MY4, anti-TLR2 TL2.1, anti-TLR4 HTA125 or isotype control IgG (10 mg/ml each) for 30 min, and the monoclonal antibodies remained present during the incubation for 24 h. The amount of IL-8 in the supernatants was measured by ELISA. The data are mean ± SD of triplicate cultures. **P < 0.01 compared with the respective controls (A, parotid saliva without LPS; B, LPS with saliva or rCD14) evaluated by one-way analysis of variance, using the Bonferroni or Dunn methods. n = 6), respectively. In contrast to human serum, the amount of LBP in both preparations was below detectable levels (< 20 ng/ml). Parotid saliva contained 10-times more CD14 than whole saliva, indicating that the parotid gland is a major source of CD14 in whole saliva. The amount of CD14 in unstimulated, whole and parotid saliva was unchanged before and after a meal, and between unstimulated and stimulated saliva, indicating that saliva CD14 is constitutively secreted into the oral cavity.
We next analyzed whether saliva CD14 confers activation of CD14-lacking epithelial SW620 cells by bacterial components as is the case for serum-derived sCD14. LPS (100 ng/ml) alone did not activate SW620, whereas saliva CD14 mediated the activation of SW620 by LPS in a dose-dependent manner to produce IL-8 ( Fig. 2A) . The saliva CD14-mediated activation of SW620 by LPS was significantly inhibited by anti-CD14 MY4, and anti-TLR4 HTA125, but not by anti-TLR2 TL2.1, which was consistent with the results obtained using 50 ng/ml of recombinant (r) CD14 as a control (Fig. 2B) . These findings clearly indicate that saliva CD14 is functionally active, and suggest that saliva CD14 is important for the maintenance of oral health. It is possible that saliva CD14 may interact with bacterial components including LPS and lactoferrin, and prevent the oral mucosa and salivary glands themselves from exacerbating innate immune responses by clearing bacterial components, as in the case of serum CD14, 14 although the biological role of saliva CD14 has to be clarified.
